Selected research
Industry Growth & Trends
Global Rosuvastatin Calcium Drug Industry Growth and Trends Forecast to 2032
Market perspective
The global Rosuvastatin Calcium Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Rosuvastatin Calcium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Rosuvastatin Calcium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Rosuvastatin Calcium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Rosuvastatin Calcium Drug include Accord Healthcare, Actavis Pharma, Angita Pharma, A-S Medication Solutions, AstraZeneca Pharmaceuticals, PD-Rx Pharmaceuticals, Hisun Pharmaceutical, Jinan Jinda and Jingxin Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Rosuvastatin Calcium Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Rosuvastatin Calcium Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rosuvastatin Calcium Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rosuvastatin Calcium Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Rosuvastatin Calcium Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Rosuvastatin Calcium Drug Market by Company
Accord Healthcare
Actavis Pharma
Angita Pharma
A-S Medication Solutions
AstraZeneca Pharmaceuticals
PD-Rx Pharmaceuticals
Hisun Pharmaceutical
Jinan Jinda
Jingxin Pharmaceutical
Lunan Pharmaceutical Group
Sandoz
Chia-Tai Tianqing Pharmaceutical
Rosuvastatin Calcium Drug Segment by Type
Capsules
Tablets
Rosuvastatin Calcium Drug Segment by Application
Clinics
Hospitals
Others
Rosuvastatin Calcium Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosuvastatin Calcium Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rosuvastatin Calcium Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosuvastatin Calcium Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rosuvastatin Calcium Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Rosuvastatin Calcium Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsules
- Tablets
Applications
- Clinics
- Hospitals
- Others
Companies covered
- Accord Healthcare
- Actavis Pharma
- Angita Pharma
- A-S Medication Solutions
- AstraZeneca Pharmaceuticals
- PD-Rx Pharmaceuticals
- Hisun Pharmaceutical
- Jinan Jinda
- Jingxin Pharmaceutical
- Lunan Pharmaceutical Group
- Sandoz
- Chia-Tai Tianqing Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Rosuvastatin Calcium Drug Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Rosuvastatin Calcium Drug Sales Estimates and Forecasts (2021-2032)
- 1.3 Rosuvastatin Calcium Drug Market by Type
- 1.3.1 Capsules
- 1.3.2 Tablets
- 1.4 Global Rosuvastatin Calcium Drug Market Size by Type
- 1.4.1 Global Rosuvastatin Calcium Drug Market Size Overview by Type (2021-2032)
- 1.4.2 Global Rosuvastatin Calcium Drug Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Rosuvastatin Calcium Drug Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Rosuvastatin Calcium Drug Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Rosuvastatin Calcium Drug Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Rosuvastatin Calcium Drug Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Rosuvastatin Calcium Drug Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Rosuvastatin Calcium Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Rosuvastatin Calcium Drug Industry Trends
- 2.2 Rosuvastatin Calcium Drug Industry Drivers
- 2.3 Rosuvastatin Calcium Drug Industry Opportunities and Challenges
- 2.4 Rosuvastatin Calcium Drug Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Rosuvastatin Calcium Drug Revenue (2021-2026)
- 3.2 Global Top Players by Rosuvastatin Calcium Drug Sales (2021-2026)
- 3.3 Global Top Players by Rosuvastatin Calcium Drug Price (2021-2026)
- 3.4 Global Rosuvastatin Calcium Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Rosuvastatin Calcium Drug Major Company Production Sites & Headquarters
- 3.6 Global Rosuvastatin Calcium Drug Company, Product Type & Application
- 3.7 Global Rosuvastatin Calcium Drug Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Rosuvastatin Calcium Drug Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Rosuvastatin Calcium Drug Players Market Share by Revenue in 2025
- 3.8.3 2025 Rosuvastatin Calcium Drug Tier 1, Tier 2, and Tier 3
4 Rosuvastatin Calcium Drug Regional Status and Outlook
- 4.1 Global Rosuvastatin Calcium Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Rosuvastatin Calcium Drug Historic Market Size by Region
- 4.2.1 Global Rosuvastatin Calcium Drug Sales in Volume by Region (2021-2026)
- 4.2.2 Global Rosuvastatin Calcium Drug Sales in Value by Region (2021-2026)
- 4.2.3 Global Rosuvastatin Calcium Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Rosuvastatin Calcium Drug Forecasted Market Size by Region
- 4.3.1 Global Rosuvastatin Calcium Drug Sales in Volume by Region (2027-2032)
- 4.3.2 Global Rosuvastatin Calcium Drug Sales in Value by Region (2027-2032)
- 4.3.3 Global Rosuvastatin Calcium Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rosuvastatin Calcium Drug by Application
- 5.1 Rosuvastatin Calcium Drug Market by Application
- 5.1.1 Clinics
- 5.1.2 Hospitals
- 5.1.3 Others
- 5.2 Global Rosuvastatin Calcium Drug Market Size by Application
- 5.2.1 Global Rosuvastatin Calcium Drug Market Size Overview by Application (2021-2032)
- 5.2.2 Global Rosuvastatin Calcium Drug Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Rosuvastatin Calcium Drug Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Rosuvastatin Calcium Drug Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Rosuvastatin Calcium Drug Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Rosuvastatin Calcium Drug Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Rosuvastatin Calcium Drug Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Rosuvastatin Calcium Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Accord Healthcare
- 6.1.1 Accord Healthcare Company Information
- 6.1.2 Accord Healthcare Business Overview
- 6.1.3 Accord Healthcare Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Accord Healthcare Rosuvastatin Calcium Drug Product Portfolio
- 6.1.5 Accord Healthcare Recent Developments
- 6.2 Actavis Pharma
- 6.2.1 Actavis Pharma Company Information
- 6.2.2 Actavis Pharma Business Overview
- 6.2.3 Actavis Pharma Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Actavis Pharma Rosuvastatin Calcium Drug Product Portfolio
- 6.2.5 Actavis Pharma Recent Developments
- 6.3 Angita Pharma
- 6.3.1 Angita Pharma Company Information
- 6.3.2 Angita Pharma Business Overview
- 6.3.3 Angita Pharma Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Angita Pharma Rosuvastatin Calcium Drug Product Portfolio
- 6.3.5 Angita Pharma Recent Developments
- 6.4 A-S Medication Solutions
- 6.4.1 A-S Medication Solutions Company Information
- 6.4.2 A-S Medication Solutions Business Overview
- 6.4.3 A-S Medication Solutions Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 A-S Medication Solutions Rosuvastatin Calcium Drug Product Portfolio
- 6.4.5 A-S Medication Solutions Recent Developments
- 6.5 AstraZeneca Pharmaceuticals
- 6.5.1 AstraZeneca Pharmaceuticals Company Information
- 6.5.2 AstraZeneca Pharmaceuticals Business Overview
- 6.5.3 AstraZeneca Pharmaceuticals Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 AstraZeneca Pharmaceuticals Rosuvastatin Calcium Drug Product Portfolio
- 6.5.5 AstraZeneca Pharmaceuticals Recent Developments
- 6.6 PD-Rx Pharmaceuticals
- 6.6.1 PD-Rx Pharmaceuticals Company Information
- 6.6.2 PD-Rx Pharmaceuticals Business Overview
- 6.6.3 PD-Rx Pharmaceuticals Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 PD-Rx Pharmaceuticals Rosuvastatin Calcium Drug Product Portfolio
- 6.6.5 PD-Rx Pharmaceuticals Recent Developments
- 6.7 Hisun Pharmaceutical
- 6.7.1 Hisun Pharmaceutical Company Information
- 6.7.2 Hisun Pharmaceutical Business Overview
- 6.7.3 Hisun Pharmaceutical Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Hisun Pharmaceutical Rosuvastatin Calcium Drug Product Portfolio
- 6.7.5 Hisun Pharmaceutical Recent Developments
- 6.8 Jinan Jinda
- 6.8.1 Jinan Jinda Company Information
- 6.8.2 Jinan Jinda Business Overview
- 6.8.3 Jinan Jinda Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Jinan Jinda Rosuvastatin Calcium Drug Product Portfolio
- 6.8.5 Jinan Jinda Recent Developments
- 6.9 Jingxin Pharmaceutical
- 6.9.1 Jingxin Pharmaceutical Company Information
- 6.9.2 Jingxin Pharmaceutical Business Overview
- 6.9.3 Jingxin Pharmaceutical Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Jingxin Pharmaceutical Rosuvastatin Calcium Drug Product Portfolio
- 6.9.5 Jingxin Pharmaceutical Recent Developments
- 6.10 Lunan Pharmaceutical Group
- 6.10.1 Lunan Pharmaceutical Group Company Information
- 6.10.2 Lunan Pharmaceutical Group Business Overview
- 6.10.3 Lunan Pharmaceutical Group Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Lunan Pharmaceutical Group Rosuvastatin Calcium Drug Product Portfolio
- 6.10.5 Lunan Pharmaceutical Group Recent Developments
- 6.11 Sandoz
- 6.11.1 Sandoz Company Information
- 6.11.2 Sandoz Business Overview
- 6.11.3 Sandoz Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Sandoz Rosuvastatin Calcium Drug Product Portfolio
- 6.11.5 Sandoz Recent Developments
- 6.12 Chia-Tai Tianqing Pharmaceutical
- 6.12.1 Chia-Tai Tianqing Pharmaceutical Company Information
- 6.12.2 Chia-Tai Tianqing Pharmaceutical Business Overview
- 6.12.3 Chia-Tai Tianqing Pharmaceutical Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Chia-Tai Tianqing Pharmaceutical Rosuvastatin Calcium Drug Product Portfolio
- 6.12.5 Chia-Tai Tianqing Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America Rosuvastatin Calcium Drug Sales by Country
- 7.1.1 North America Rosuvastatin Calcium Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Rosuvastatin Calcium Drug Sales by Country (2021-2026)
- 7.1.3 North America Rosuvastatin Calcium Drug Sales Forecast by Country (2027-2032)
- 7.2 North America Rosuvastatin Calcium Drug Market Size by Country
- 7.2.1 North America Rosuvastatin Calcium Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Rosuvastatin Calcium Drug Market Size by Country (2021-2026)
- 7.2.3 North America Rosuvastatin Calcium Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Rosuvastatin Calcium Drug Sales by Country
- 8.1.1 Europe Rosuvastatin Calcium Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Rosuvastatin Calcium Drug Sales by Country (2021-2026)
- 8.1.3 Europe Rosuvastatin Calcium Drug Sales Forecast by Country (2027-2032)
- 8.2 Europe Rosuvastatin Calcium Drug Market Size by Country
- 8.2.1 Europe Rosuvastatin Calcium Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Rosuvastatin Calcium Drug Market Size by Country (2021-2026)
- 8.2.3 Europe Rosuvastatin Calcium Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Rosuvastatin Calcium Drug Sales by Country
- 9.1.1 Asia-Pacific Rosuvastatin Calcium Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Rosuvastatin Calcium Drug Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Rosuvastatin Calcium Drug Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Rosuvastatin Calcium Drug Market Size by Country
- 9.2.1 Asia-Pacific Rosuvastatin Calcium Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Rosuvastatin Calcium Drug Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Rosuvastatin Calcium Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Rosuvastatin Calcium Drug Sales by Country
- 10.1.1 South America Rosuvastatin Calcium Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Rosuvastatin Calcium Drug Sales by Country (2021-2026)
- 10.1.3 South America Rosuvastatin Calcium Drug Sales Forecast by Country (2027-2032)
- 10.2 South America Rosuvastatin Calcium Drug Market Size by Country
- 10.2.1 South America Rosuvastatin Calcium Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Rosuvastatin Calcium Drug Market Size by Country (2021-2026)
- 10.2.3 South America Rosuvastatin Calcium Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Rosuvastatin Calcium Drug Sales by Country
- 11.1.1 Middle East and Africa Rosuvastatin Calcium Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Rosuvastatin Calcium Drug Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Rosuvastatin Calcium Drug Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Rosuvastatin Calcium Drug Market Size by Country
- 11.2.1 Middle East and Africa Rosuvastatin Calcium Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Rosuvastatin Calcium Drug Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Rosuvastatin Calcium Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Rosuvastatin Calcium Drug Value Chain Analysis
- 12.1.1 Rosuvastatin Calcium Drug Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Rosuvastatin Calcium Drug Production Mode & Process
- 12.2 Rosuvastatin Calcium Drug Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Rosuvastatin Calcium Drug Distributors
- 12.2.3 Rosuvastatin Calcium Drug Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst